Rhnull phenotype is a rare blood group with a frequency of approximately 1 in 6 million individuals, transmitted via an autosomal recessive mode. It is characterized by the weak (Rhmod) or lack (Rhnull) of expression of all Rh antigens on the red cells. The clinical significance of its assessment is that such patients with Rhnull syndrome are associated with chronic hemolytic anemia of varying degrees. Another clinical importance is that such subjects readily form alloantibodies when exposed to Rh antigens. We report herein a rare Rhnull phenotype in a sibling, which was detected as a part of the difficult sample work-up for red cell antibody screening and identification.
INTRODUCTION
The Rh-deficiency syndrome is a rare genetic disorder of red blood cells (RBCs) with a reported frequency of approximately 1 in 6 million individuals, transmitted via an autosomal recessive mode generally via consanguineous genealogy 1, 2 . The characteristic hallmark of Rhnull phenotype is the lack of all Rh antigens on the RBCs. The Rhnull patients manifest a mild to moderate hemolytic anemia, and their RBCs show changes in morphology (stomatocytosis) and abnormalities in plasma membranes [3] [4] [5] [6] . It results in the same clinical syndrome characterized by chronic hemolysis of varying severities, with stomatocytosis, spherocytosis, increased osmotic fragility, altered phospholipids asymmetry, altered cell volume, defective cation fluxes, and elevation in Na+/K+ ATPase activity 2 .
To the best of our knowledge, this is the first report about individuals with identified Rhnull syndrome across Iran. 
Case presentation
. These results suggested the presence of clinically significant alloantibodies against multiple negative antigens or a high-prevalence antigen. An antibody screening test result was negative for the patient's brother. A home-made available three-cell antigen panel (IBTO mini-panel) was used for the antibody screening procedure in which the patient's plasma was added to RBCs without papain enzyme using the Low Ionic Strength Saline (LISS). IBTO mini-3cell panel and antibody identification 11cell kit and also selected cells were validated within the two-year period using commercial CE marked Diamed kits. The antibody screening test was performed twice in parallel using IBTO produced kits and Diamed kits. The results were compared and in case of positive results, the 11cells antibody ID panel from Diamed Company was used simultaneously with IBTO 11cells antibody ID panel. IBTO homemade antibody ID panel and selected cells were used to exclude and include alloantibodies. Column agglutination method with antiglobulin gel card (INVITROGEL AHG coombs-Germany) was used for the antibody screening test. The gel cards were incubated at 37 °C for 15 minutes, and then centrifuged for 10 minutes. Standard tube methods (Bio-Rad AHG-Germany) were used for antibody identification and selected cell tests. Clinically significant alloantibodies were defined as those antibodies that potentially could cause RBC destruction based on the reactivity at 37 °C and/or anti-human globulin (AHG) phase. The patient and her brother extended phenotyping showed that they were negative for D, C, E, c, e RBC antigens, indicating they were strongly suspicious of being the rare Rhnull phenotype. Adsorption and elution studies in Anti-human globulin (AHG, CE-Immunodiagnostika, Am Seerain 13 Germany, Eschelbronn) did not reveal the presence of D, C, E, c, e, RBC antigens in the blood obtained from both patients. We performed Rh phenotyping with two sources of antisera (Diagast 251/AV.AVINEE-59120 Loos, France and CEImmunodiagnostika, Am Seerain 13 Germany, Eschelbronn). Positive and negative control tests were performed for each antigen according to the manufacturer's recommendations. Based on these collective findings, we interpreted these results as being strongly suggestive of the Rhnull phenotype with a clinically significant anti-Rh29 identified in serum of the female patient whose data are shown in Table 1 . . A few Rhnull individuals were identified because of the presence of Rh antibodies in their sera, while others were detected with routine Rh phenotyping of the red cells. Interestingly, three cases were identified when the patients were investigated for determination of the appropriate blood group for blood transfusion, hemolytic anemia and abnormal red cell morphology 10 . It seems that consanguineous marriage plays an important role in the creation of this type of blood group. In the current study, our patients were siblings and were born to consanguineous parents. Antibody in immunized Rhnull individuals is considered to be "anti-total Rh" and has been given the numerical designation anti-Rh29 9 . In this report, the female patient probably got immunized in pregnancy or childbirth and the antibody presented in patient's sera reacted with all cells tested, and therefore was labeled as anti-total Rh (Anti-Rh29). But in the male patient with no history of blood transfusion, no antibody was present. The clinical, hematological and biological features associated with this rare disorder show that it affects the membrane integrity of red blood cells and, as evident in this report, it is associated with spherocytic hemolytic anemia, stomatocytosis and increased osmotic fragility of red cells 9 . In the recent study, the male patient underwent splenectomy because of hereditary spherocytosis anemia. Further genetic studies are needed for the underlying mutation for characterization of regulator or amorphous type. Iran has been a member of the International Society for Blood Transfusion (ISBT) working party on rare donors since 2010
11. Recognition of individuals with Rhnull phenotype was reported to the working party in order to be added to the list of countries with Rhnull donors. 
